Atlas Venture


Early-stage venture firm focused on creating and building biotechnology companies. Atlas uses a seed-led model, incubator/co-founding activity, and a long-term partnership approach to translate scientific innovation into medicines. The firm emphasizes a science-first, patient-centric culture and has operated for over 30 years.

Industries

biotechnology
health-care
pharmaceutical
venture-capital-b37d

Nr. of Employees

small (1-50)

Atlas Venture

300 Technology Square, 8th Floor, Cambridge, MA 02139, USA


Portfolio

Next-generation gene therapies enabling delivery of large genes.

#Gene therapy; delivery for large genes

Targets RNA-modifying proteins for precision cancer therapies.

#RNA-modifying proteins; precision oncology

Restoring metabolic balance to treat NASH; NASDAQ: AKRO (2019).

#Metabolic disease; NASH

RNAi-based drugs for severe diseases; NASDAQ: ALNY (2004).

#RNAi therapeutics

Developing first-in-class precision medicines for cancer and other diseases.

#Precision medicines for cancer

Engineered B cells as medicines.

#Engineered B cell therapeutics

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.